JP2024500288A5 - - Google Patents
Info
- Publication number
- JP2024500288A5 JP2024500288A5 JP2023530278A JP2023530278A JP2024500288A5 JP 2024500288 A5 JP2024500288 A5 JP 2024500288A5 JP 2023530278 A JP2023530278 A JP 2023530278A JP 2023530278 A JP2023530278 A JP 2023530278A JP 2024500288 A5 JP2024500288 A5 JP 2024500288A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063115969P | 2020-11-19 | 2020-11-19 | |
| US63/115,969 | 2020-11-19 | ||
| US202163154652P | 2021-02-26 | 2021-02-26 | |
| US63/154,652 | 2021-02-26 | ||
| US202163158849P | 2021-03-09 | 2021-03-09 | |
| US63/158,849 | 2021-03-09 | ||
| US202163173361P | 2021-04-10 | 2021-04-10 | |
| US63/173,361 | 2021-04-10 | ||
| PCT/US2021/060151 WO2022109307A1 (en) | 2020-11-19 | 2021-11-19 | Treatment of kras mutant cancers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024500288A JP2024500288A (ja) | 2024-01-09 |
| JPWO2022109307A5 JPWO2022109307A5 (https=) | 2024-11-27 |
| JP2024500288A5 true JP2024500288A5 (https=) | 2024-11-27 |
Family
ID=81709695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530278A Pending JP2024500288A (ja) | 2020-11-19 | 2021-11-19 | Ｋｒａｓ変異癌の治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240016781A1 (https=) |
| EP (1) | EP4247806A4 (https=) |
| JP (1) | JP2024500288A (https=) |
| KR (1) | KR20230148144A (https=) |
| AU (1) | AU2021381423A1 (https=) |
| CA (1) | CA3198938A1 (https=) |
| IL (1) | IL302925A (https=) |
| MX (1) | MX2023005806A (https=) |
| WO (1) | WO2022109307A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022271290A1 (en) | 2021-05-07 | 2023-11-23 | Kymera Therapeutics, Inc. | Cdk2 degraders and uses thereof |
| EP4376839A4 (en) * | 2021-07-26 | 2025-10-15 | Vincerx Pharma Inc | SELECTIVE CDK9 INHIBITOR FOR THE TREATMENT OF RAS MUTANT CANCER |
| CN119522225A (zh) | 2022-09-29 | 2025-02-25 | 广州嘉越医药科技有限公司 | 大环衍生物及其应用 |
| IL319991A (en) * | 2022-10-03 | 2025-06-01 | Prelude Therapeutics Inc | Cancer treatment using combinations of SMARCA2 inhibitors and KRAS-targeted therapies |
| WO2024173833A1 (en) * | 2023-02-16 | 2024-08-22 | Mei Pharma, Inc. | Combination of a cdk inhibitor and a flt3 inhibitor for the treatment of cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8563596B2 (en) * | 2006-06-21 | 2013-10-22 | Piramal Enterprises Limited | Enantiomerically pure compounds for the treatment of proliferative disorders |
| CN104220066A (zh) * | 2010-11-19 | 2014-12-17 | 皮拉马尔企业有限公司 | 紫杉醇和cdk抑制剂药物组合物 |
| CN105530931B (zh) * | 2013-07-12 | 2019-11-08 | 皮拉马尔企业有限公司 | 用于治疗黑素瘤的药物组合 |
| RU2726367C2 (ru) * | 2016-03-28 | 2020-07-13 | Пресидж Байосайенсиз, Инк. | Фармацевтические комбинации для лечения злокачественной опухоли |
| US20220175750A1 (en) * | 2018-04-23 | 2022-06-09 | The Regents Of The University Of California | Sustained release formulation for local delivery of cdk9 inhibitors |
| WO2020046966A1 (en) * | 2018-08-27 | 2020-03-05 | Kura Oncology, Inc. | Treatment of adenocarcinomas with mapk pathway inhibitors |
| JP7377679B2 (ja) * | 2018-11-19 | 2023-11-10 | アムジエン・インコーポレーテツド | がん治療のためのｋｒａｓｇ１２ｃ阻害剤及び１種以上の薬学的に活性な追加の薬剤を含む併用療法 |
| AU2020271908B2 (en) * | 2019-04-11 | 2025-12-04 | Mei Pharma, Inc. | Voruciclib poly morphs and methods of making and using thereof |
| CA3148504A1 (en) * | 2019-08-08 | 2021-02-11 | Institute For Cancer Research D/B/A/ The Research Institute Of Fox Chase Cancer Center | Combination therapy for treatment of cancer |
| WO2022217133A1 (en) * | 2021-04-10 | 2022-10-13 | Mei Pharma, Inc. | Voruciclib dosing regimens and methods of treatment including the same |
-
2021
- 2021-11-19 WO PCT/US2021/060151 patent/WO2022109307A1/en not_active Ceased
- 2021-11-19 EP EP21895697.7A patent/EP4247806A4/en active Pending
- 2021-11-19 US US18/253,481 patent/US20240016781A1/en active Pending
- 2021-11-19 IL IL302925A patent/IL302925A/en unknown
- 2021-11-19 CA CA3198938A patent/CA3198938A1/en active Pending
- 2021-11-19 JP JP2023530278A patent/JP2024500288A/ja active Pending
- 2021-11-19 MX MX2023005806A patent/MX2023005806A/es unknown
- 2021-11-19 KR KR1020237020122A patent/KR20230148144A/ko active Pending
- 2021-11-19 AU AU2021381423A patent/AU2021381423A1/en active Pending